EUVIMEDEUVIMED entdecken
Crossref

MARCHF1 promotes breast cancer through accelerating REST ubiquitylation and following TFAM transcription

Jutao Li, Zhenming Gao

Cell Biology International · 2025

DOI: 10.1002/cbin.12255 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Biology International, 2025. Verfasst von Jutao Li und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatobiliary and Pancreatic Surgery, The Second Hospital of Dalian Medical University, Dalian, China. Hauptthemen laut MEDLINE: Breast Neoplasms, Mitochondrial Proteins, Transcription Factors, DNA-Binding Proteins. Die Arbeit nennt 68 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Breast cancer has become the leading cause of death in women. Membrane associated ring‐CH‐type finger 1 (MARCHF1) is associated with the development of various types of cancer, but the exact role of MARCHF1 in breast cancer remains unclear. In our study, the higher MARCHF1 expression was observed in tumor samples of patients with breast cancer and then the role of MARCHF1 in breast cancer was further evaluated. Overexpression of MARCHF1 contributed to proliferation of cancer cells and inhibition of oxidative stress. Knockdown of MARCHF1 reduced breast cancer cell proliferation, increased mitochondrial dysfunction induced by oxidative stress, eventually aggravating cell death. In vivo, MARCHF1 promoted the tumor growth and oppositely, MARCHF1 silencing suppressed the tumor development. Moreover, MARCHF1 interacted with repressor Element‐1 silencing transcription factor (REST) and facilitated its ubiquitylation and degradation. Subsequently, REST negatively regulated the transcription of mitochondrial transcription factor A (TFAM). The subcutaneous tumor formation assay in nude mice also supported these conclusions. In details, knockdown of MARCHF1 upregulated the protein expression of REST and downregulated the mRNA level of TFAM. On the contrary, MARCHF1 overexpression exhibited opposite effects. Thus, MARCHF1 is conducive to the progression of breast cancer via promoting the ubiquitylation and degradation of RSET and then the transcription of TFAM. Downregulating MARCHF1 could provide a novel direction for treating breast cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsMitochondrial ProteinsTranscription FactorsDNA-Binding ProteinsRepressor ProteinsMembrane ProteinsHumansFemaleUbiquitinationAnimalsMice, NudeMiceCell Line, TumorCell ProliferationGene Expression Regulation, NeoplasticMice, Inbred BALB CMitochondriaOxidative StressTranscription, GeneticRE1-Silencing Transcription Factor

Stichwörter der Autor:innen

MARCHF1RESTTFAMbreast canceroxidative stress

Substanzen

Mitochondrial ProteinsTranscription FactorsDNA-Binding ProteinsRepressor ProteinsMembrane ProteinsRE1-Silencing Transcription FactorTFAM protein, human

Autor:innen und Institutionen

  • Department of Hepatobiliary and Pancreatic Surgery, The Second Hospital of Dalian Medical University, Dalian, China.
  • Organ Transplantation Center, The Second Hospital of Dalian Medical University, Dalian, China.
  • Department of Thyroid Surgery, Dalian Municipal Central Hospital, Dalian, China.

Zitieren

APA

Li, J., & Gao, Z. (2025). MARCHF1 promotes breast cancer through accelerating REST ubiquitylation and following TFAM transcription. Cell Biology International. https://doi.org/10.1002/cbin.12255

Vancouver

Li J, Gao Z. MARCHF1 promotes breast cancer through accelerating REST ubiquitylation and following TFAM transcription. Cell Biology International. 2025. doi:10.1002/cbin.12255

BibTeX
@article{Li2025,
  author = {Li, Jutao and Gao, Zhenming},
  title = {MARCHF1 promotes breast cancer through accelerating REST ubiquitylation and following TFAM transcription},
  journal = {Cell Biology International},
  year = {2025},
  doi = {10.1002/cbin.12255}
}
Kostenlos starten →